Effects of sumac on metabolic syndrome

Effects of Rhus Coriaria(Sumac) supplementation on indicators of metabolic syndrome in adult with metabolic syndrome

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200106046022N1

Enrollment

Registered

2020-04-08

Start date

2020-02-04

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrom. Metabolic syndrome

Interventions

Intervention 1: Intervention group: 500 mg capsules of sumac daily, two with food for 6 weeks in the first period of the intervention. In the second period of the intervention of this group, they are

Eligibility

Sex/Gender

All

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Adults 20-55 years old Metabolic syndrome based on modified ATPIII criteria

Exclusion criteria

Exclusion criteria: Having cardiovascular, liver, kidney, thyroid and diabetes diseases Pregnancy and lactation Follow a special diet Use of drugs that affect appetite, blood pressure, inflammation, fat metabolism and carbohydrates Use of multivitamin-mineral supplements, fatty acids and herbal remedies

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.	—

Secondary

Measure	Time frame
Triglyceride. Timepoint: At the beginning and end of each intervention period. Method of measurement: Existing commercial kits.;High density Lipoprotein Cholesterol. Timepoint: At the beginning and end of each intervention period. Method of measurement: Existing commercial kits.;Blood pressure. Timepoint: At the beginning and end of each intervention period. Method of measurement: Barometer.;Waist size. Timepoint: At the beginning and end of each intervention period. Method of measurement: Meters irreversible.;Weight. Timepoint: At the beginning and end of each intervention period. Method of measurement: ?Digital Balance.;BMI. Timepoint: At the beginning and end of each intervention period. Method of measurement: Divide the weight by the square of the height.	—

Measure

Time frame

Triglyceride. Timepoint: At the beginning and end of each intervention period. Method of measurement: Existing commercial kits.;High density Lipoprotein Cholesterol. Timepoint: At the beginning and end of each intervention period. Method of measurement: Existing commercial kits.;Blood pressure. Timepoint: At the beginning and end of each intervention period. Method of measurement: Barometer.;Waist size. Timepoint: At the beginning and end of each intervention period. Method of measurement: Meters irreversible.;Weight. Timepoint: At the beginning and end of each intervention period. Method of measurement: ?Digital Balance.;BMI. Timepoint: At the beginning and end of each intervention period. Method of measurement: Divide the weight by the square of the height.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvane Saneei

Esfahan University of Medical Sciences

saneeip@yahoo.com+98 31 3792 3159

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026